{"id":"W4409986064","doi":"10.1001/jamadermatol.2025.0982","title":"Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents","year":2025,"lang":"en","type":"article","venue":"JAMA Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Occupational Cancer Research Centre; XLV Diagnostics (Canada); SKiN Health","funders":"","keywords":"Medicine; Eczema Area and Severity Index; Placebo; Atopic dermatitis; Randomized controlled trial; Adverse effect; Internal medicine; Clinical trial; Severity of illness; Pediatrics; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000437196,0.0001614478,0.0004514785,0.0002817477,0.00007460854,0.0000195192,0.00008911121,0.0002238151,0.0000211575],"category_scores_gemma":[0.0002288884,0.0001607772,0.00005703645,0.0001847911,0.00007764211,0.00009283492,0.00007145937,0.0001669564,0.00002754972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002647725,"about_ca_system_score_gemma":0.00009921264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000136848,"about_ca_topic_score_gemma":0.00004593285,"domain_scores_codex":[0.9988584,0.00007412301,0.0003425177,0.0003084103,0.00006493049,0.0003516436],"domain_scores_gemma":[0.9994011,0.0001272506,0.00004119745,0.0002006978,0.00008262032,0.0001471589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001319961,0.0002153978,0.9110982,0.002440376,0.00006833328,0.0007034503,0.0004400029,0.000007038675,0.00002602113,0.002909366,0.07122575,0.009546064],"study_design_scores_gemma":[0.01498613,0.00004009529,0.9518113,0.001684011,0.00009066263,0.003015953,0.0002160831,0.003339294,0.001711803,0.004387538,0.01845107,0.0002661126],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738256,0.0008400767,0.0008769131,0.02046235,0.000213949,0.0009211889,0.00003118481,0.00006486577,0.002763859],"genre_scores_gemma":[0.9774978,0.00007189414,0.0005801151,0.02137123,0.00002308591,0.0001879395,0.00003577099,0.00001185895,0.0002203521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05277467,"threshold_uncertainty_score":0.6556302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00868481131928063,"score_gpt":0.2800234437918701,"score_spread":0.2713386324725894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}